Şunu aradınız:: biphosphonates (İngilizce - Maltaca)

the presence of osteoblastic metastases which take up technetium (99mtc)-labelled biphosphonates should be confirmed prior to therapy.
il-preŜenza ta’ metastasi ostejoblastika li tieħu biphosphonates immarkati b’sustanza radjuattiva ta’ technetium (99mtc) għandha tiāi kkonfermata qabel it-terapija.

it should not be used concurrently with other biphosphonates if an interference is shown on the technetium (99mtc)-labelled biphosphonate bone scans.
m’għandux jintuŜa fl-istess ħin ma’ biphosphonates oħra jekk tidher xi interferenza fl-iskan tal-għadam meħuda b’biphosphonate mmarkat b’sustanza radjuattiva ta’ technetium (99mtc).

quadramet is indicated for the relief of bone pain in patients with multiple painful osteoblastic skeletal metastases which take up technetium (99mtc)-labelled biphosphonates on bone scan.
quadramet huwa indikat għas-serħan mill-uāigħ fl-għadam, f’pazjenti b’metastasi skeletali ostejoblastika multipla bl-uāigħ, li tieħu biphosphonates immarkati b’sustanza radjuattiva ta’ technetium (99mtc) għal skan tal-għadam.

although the aetiology is considered to be multifactorial (including corticosteroid use, biphosphonates, alcohol consumption, severe immunosuppression, higher body mass index), cases of osteonecrosis have been reported in patients with advanced hiv-disease and/or long-term exposure to cart.
għalkemm l-etjoloġija hija kkunsidrata bħala multifattorjali (li tinkludi l-użu ta’ kortikosterojdi, bifosfonati, konsum tal-alkoħol, immunosoppressjoni severa, indiċi tal-massa tal-ġisem iżjed għoli), kienu rrappurtati każijiet ta’ osteonekrożi f’pazjenti b’mard tal-hiv avvanzat u/jew esponiment fit-tul għas-cart.